Fresenius Medical Care AG
FMCQF
$46.52
$1.814.04%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.13% | 6.00% | 0.16% | 0.94% | -2.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.13% | 6.00% | 0.16% | 0.94% | -2.60% |
| Cost of Revenue | 7.18% | 4.78% | 0.94% | 3.81% | -1.53% |
| Gross Profit | 15.26% | 9.77% | -2.21% | -6.80% | -5.81% |
| SG&A Expenses | -0.79% | 8.25% | -6.18% | -1.64% | -3.78% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 93.78% | 55.50% | 169.49% | 51.63% | -362.18% |
| Total Operating Expenses | 6.80% | 5.55% | -0.02% | 3.06% | -3.58% |
| Operating Income | 34.77% | 11.36% | 2.37% | -18.33% | 9.72% |
| Income Before Tax | 12.50% | 8.89% | 53.95% | -48.30% | 63.20% |
| Income Tax Expenses | -31.35% | -16.66% | 49.77% | -30.14% | 33.08% |
| Earnings from Continuing Operations | 31.86% | 19.41% | 55.35% | -54.42% | 81.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -9.64% | 7.17% | 21.42% | 26.15% | 17.91% |
| Net Income | 37.18% | 27.00% | 106.59% | -64.75% | 155.09% |
| EBIT | 34.77% | 11.36% | 2.37% | -18.33% | 9.72% |
| EBITDA | 19.16% | 5.30% | -1.11% | -14.78% | 2.46% |
| EPS Basic | 37.80% | 26.99% | 106.63% | -64.76% | 155.10% |
| Normalized Basic EPS | 55.29% | 25.21% | 24.80% | -10.34% | 30.82% |
| EPS Diluted | 37.68% | 26.99% | 108.21% | -65.97% | 155.10% |
| Normalized Diluted EPS | 55.29% | 25.21% | 24.80% | -10.34% | 30.82% |
| Average Basic Shares Outstanding | -0.45% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | -0.45% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | 19.82% | -- |
| Payout Ratio | -- | 0.00% | -- | -- | -- |